Digital Visibility of Pediatric Extracranial Solid Tumors on YouTube: A Comprehensive Infodemiology and Infoveillance Study
Journal of Indian Association of Pediatric Surgeons · 2026-11 · 31 (6) · 937-948
DOI: 10.4103/jiaps.jiaps_113_26 ↗Abstract
A BSTRACT Background: YouTube is the dominant audiovisual health information platform globally, yet digital visibility of pediatric extracranial solid tumors remains uncharacterized. Objectives: The objectives of this study were as follows: to characterize the discoverable YouTube video ecosystem for five pediatric extracranial solid tumors – Wilms tumor, neuroblastoma, hepatoblastoma, rhabdomyosarcoma, and germ cell tumors – and compare content availability and engagement across disease groups and query categories. Methodology: This was a cross-sectional infoveillance study using the YouTube Data API v3. Ten prespecified queries (five – disease awareness [DA] and five – surgical procedure [SP]) were submitted without filters to pool exhaustion or a 600-result ceiling. Analyses included Mann–Whitney U tests, Kruskal–Wallis tests with a Bonferroni correction, and Spearman correlations. Results: All 10 queries exhausted the result pool, yielding 2705 videos from 1712 channels (143,798,186 views). The neuroblastoma SP query returned only 25 videos – a 21-fold disparity versus the DA query ( n = 529). Wilms tumor had the fewest videos ( n = 135) but the highest median view count (1628) and views per day (1.05). Neuroblastoma showed the highest engagement rate (0.0157) despite the lowest median views (326). SP videos had higher view counts than DA videos (847 vs. 428; P < 0.001); DA videos showed a higher rate-based engagement ( P < 0.001). The top 1% captured 83.7% of views; 60.7% had fewer than 1000 lifetime views. Caption availability was 6.4%. Conclusion: Profound digital scarcity exists for neuroblastoma and Wilms tumor surgical content, with extreme view concentration and critically low accessibility. These findings provide an evidence-based framework for targeted content production by pediatric surgery and oncology societies.
EUVIMED